Immunotherapy in Non-Small Cell Lung Cancer

AGEAN: Analysis Explores Impact of Post-Surgical MRD Status in NSCLC
Other analyses suggest that lack of ctDNA clearance with neoadjuvant therapy or with MRD postsurgery leads to worse outcomes.
Advertisement
Advertisement